DISABLED VETERANS HAWAII LLC

Disabled Veterans Hawaii LLC specializes in the manufacturing of pharmaceutical preparations and in-vitro diagnostic substances, serving critical needs within the federal healthcare supply chain. The company demonstrates deep technical expertise in GMP-compliant production of active pharmaceutical ingredients and finished dosage forms, including complex formulations such as hydroxychloroquine sulfate, sevelamer carbonate, and fexofenadine HCl. Their capability extends to the precise compounding and packaging of specialty medications for VA medical centers, ensuring adherence to stringent FDA and VA pharmacopeial standards. A demonstrated ability to manage multi-product manufacturing workflows and maintain supply continuity for high-demand therapeutics distinguishes their operational rigor. They also possess experience in supporting medical device and audio-visual infrastructure upgrades, indicating adaptive technical capacity beyond pharmaceuticals. The contractor maintains an exclusive and sustained relationship with the Department of Veterans Affairs, consistently delivering mission-critical pharmaceuticals and medical supplies to VA manufacturing and distribution networks. Their work directly supports VA’s internal compounding operations at regional centers such as Tucson and National CMOP, reinforcing a trusted partnership built on reliability, regulatory compliance, and timely fulfillment of complex therapeutic requirements. Industry focus centers on pharmaceutical preparation manufacturing (NAICS 325412) and in-vitro diagnostic substance production (325413), with secondary involvement in pharmacy benefit administration (524292). This positions them as a niche supplier within the federal medical logistics sector, specializing in high-integrity, low-volume, high-complexity drug manufacturing for veteran-specific treatment protocols. As a Service-Disabled Veteran-Owned Business structured as a 2J entity, Disabled Veterans Hawaii LLC leverages its certification to align mission with ownership, operating from its base in Waipahu, Hawaii. The company’s government market positioning is defined by its certified status, regulatory compliance, and focused service to the VA’s pharmaceutical supply ecosystem.